Category: Uncategorized

May 5, 2026

What the FDAs 503B GLP-1 Proposal Means for Peptide Patients

The FDA proposal to add GLP-1 to 503B outsourcing-facility regulations reshapes the peptide-therapy landscape. GLP-1 and peptides both live in the compounding-pharmacy space. They compete for prescriber attention and patient…